Newsletter
Careers
News
Contact
LinkedIn
Twitter
facebook
fr
Solutions
Services
Biomarker Solutions
Discovery and Non-Clinical Services
Clinical Biomarkers
MS based Biomarker Services
Immune Monitoring
Basophil Activation Test (BAT)
Cell Enumeration
Cellular Phenotyping
Cellular Proliferation
Intracellular Cytokine Staining (ICS) assays
Fluorescence-Activated Cell Sorting (FACS)
MDSC Assays
Pathway Mapping
Surface Profiling
Receptor Occupancy (RO) Assays
Proteomics
Antigen Presentation
B-cell Maturation Antigen (BCMA)
Biomarkers in FFPE
HCP Analysis
Immunoassays
Immuno-MRM Assays
Immunogenicity Assessment
NEOEPITOPE DIRECT™
PK by MS
Genomics
All Genomic Services
Digital PCR (dPCR)
Quantitative PCR
RNA Sequencing Services
Histopathology
All Histopathology Services
Digital Pathology Solutions
IHC-IF
IHC Biomarker Menu
ISH
Pathology Team
Data Analysis
Bioinformatics and Biostatistics
Antigen Atlas
TM
Database
CellEngine® Software
Genomic Data Analysis
Regulatory Expertise
Companion Diagnostic (CDx) Services
Quality Management Systems
Clinical Laboratory Services
Technologies
Ella™
ELISA
ELISpot and FluoroSpot
Flow Cytometry
Olink® PEA Technology
Mass Cytometry (CyTOF)
Mass Spectrometry
MSD®
Nanostring
TM
RareCyte
Single-Cell Sequencing
Spatial Biology
Therapeutic Expertise
Cell Therapy
Infectious Diseases
Immunology
Neurosciences
Oncology
Targeted Protein Degraders
Phases
Biorepository Services
Clinical Site Training
Global PBMC Processing Services
Kitting Solutions
Sample Logistics
Science Hub
Brochures & Infographics
Case Studies & Whitepapers
CellTalk Blog
News
Posters
Scientific Publications
Videos
Webcasts & Webinars
Events
About us
Services
Biomarker Solutions
Discovery and Non-Clinical Services
Clinical Biomarkers
MS based Biomarker Services
Immune Monitoring
Basophil Activation Test (BAT)
Cell Enumeration
Cellular Phenotyping
Cellular Proliferation
Intracellular Cytokine Staining (ICS) assays
Fluorescence-Activated Cell Sorting (FACS)
MDSC Assays
Pathway Mapping
Surface Profiling
Receptor Occupancy (RO) Assays
Proteomics
Antigen Presentation
B-cell Maturation Antigen (BCMA)
Biomarkers in FFPE
HCP Analysis
Immunoassays
Immuno-MRM Assays
Immunogenicity Assessment
NEOEPITOPE DIRECT™
PK by MS
Genomics
All Genomic Services
Digital PCR (dPCR)
Quantitative PCR
RNA Sequencing Services
Histopathology
All Histopathology Services
Digital Pathology Solutions
IHC-IF
IHC Biomarker Menu
ISH
Pathology Team
Data Analysis
Bioinformatics and Biostatistics
Antigen Atlas
TM
Database
CellEngine® Software
Genomic Data Analysis
Regulatory Expertise
Companion Diagnostic (CDx) Services
Quality Management Systems
Clinical Laboratory Services
Technologies
Ella™
ELISA
ELISpot and FluoroSpot
Flow Cytometry
Olink® PEA Technology
Mass Cytometry (CyTOF)
Mass Spectrometry
MSD®
Nanostring
TM
RareCyte
Single-Cell Sequencing
Spatial Biology
Therapeutic Expertise
Cell Therapy
Infectious Diseases
Immunology
Neurosciences
Oncology
Targeted Protein Degraders
Phases
Biorepository Services
Clinical Site Training
Global PBMC Processing Services
Kitting Solutions
Sample Logistics
Webinar
Predicting Immune Checkpoint Inhibitor Response Directly from Tumor RNA-Sequencing Data
Speakers:
Pieter Mestdagh, PhD
Computational Biology Manager, CellCarta
Topics in this presentation include:
A unique computational pipeline that defines several characteristics directly from the RNA-sequencing profile of a tumor
How this analysis is compatible with formalin-fixed paraffin-embedded (FFPE) tumor samples and does not require a matched germline DNA sample